Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2007.0054



We can do better - Decisions on Primary Prevention
Dimitrios H. Roukos MD.

Basic sciences discoveries increasingly alter medical though and routine clinical practice. With the advent and refinement of innovative high-throughput technologies, including “omics” and RNA interference and efforts for their use in unbiased studies begins to be influenced oncological practice. Currently, genomewide association studies have been able to examine interpatient differences in inherited genetic variability at an unprecedented level of resolution, thanks to the development of microarrays, or chips, capable of assessing more 500,000 to 1 million single-nucleotide polymorphisms (SNPs) in a single sample. This “SNP-chip” technology capitalizes on a catalogue of common human genetic variations that is provided by the HapMap Project, which was made possible by the completion of the consensus human-genome sequence [1].

Online ISSN : 1109 - 7647
   Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 3 February 2004